PACB — Pacific Biosciences of California Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Pacific Biosciences of California Inc (PACB), worth $1.97M combined. Over the quarter 1 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $1.62M | 0.00% | -61.2% |
| Quadrature | $311.90K | 0.00% | +65% |
| Pinegrove | $34.58K | 0.47% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.